Obesity News

The prevalence of obesity in the U.S. more than doubled from 1990 to 2021, and the number of Americans with obesity could reach 260 million by 2050 if trends do not change, researchers reported in The Lancet.

A pilot study revealed that patients treated with the antipsychotic olanzapine plus an intestinal microsomal triglyceride transfer protein inhibitor had an 82% reduction in postprandial triglycerides vs. those treated with olanzapine alone.

SAN ANTONIO — Redevelopment of low-income minority communities may help to reduce obesity disparities in this patient population, according to findings presented at ObesityWeek.

SAN ANTONIO — Due to structural barriers such as low income and inadequate insurance coverage, Black and Hispanic adults were more likely to ration prescription drugs to save money, researchers reported.

Regardless of sex, high- vs. moderate-intensive exercise may better reduce ghrelin levels, but its effect on hunger perceptions may differ between men and women, according to results published in the Journal of the Endocrine Society.

SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses and weekly injectables for efficacy and safety, a speaker reported.

SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.

SAN ANTONIO — In this Healio video exclusive from ObesityWeek, Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, FAAP, FAHA, FTOS, discusses equitable access to obesity care and treatments in the U.S.

SAN ANTONIO — Higher concentrations of some phthalate and plasticizer metabolites were associated with higher odds of metabolic syndrome in U.S. adolescents and young adults, according to an analysis presented at ObesityWeek.